Based on this review, in the CY 2026 OPPS/ASC proposed rule we stated that we believed it would be appropriate to propose the use of hospitals' median payer-specific negotiated charges for MAOs, to be collected on the Medicare cost report as described previously, within a proposed new methodology for calculating the MS-DRG relative weights to reflect a more market-based approach, using our authority under sections 1886(d)(4)(A), 1886(d)(4)(B), and 1886(d)(4)(C) of the Act
Researchers continue investigating these research peptides in controlled laboratory environments to better understand peptide structure, receptor interactions, and biochemical processes
Avicenna J Med Biotechnol
doi: 10.3109/10799890903563768
And if you went the other direction, drawing 40 units from a 5mg/ml vial, you would inject 2.0mg, double your intended dose